White Paper
The Life Sciences Innovation Report
A data-driven view of the emerging trends that are accelerating biopharmaceutical R&D innovation
What is life science innovation and how do we track it?
Innovation means many things to many people, and both biomedical and clinical innovation is foundational to commercial success in life sciences. With this in mind, Clarivate Analytics, in conjunction with the Pistoia Alliance (a global, not-for-profit alliance of life science companies, vendors, publishers, and academic groups that work together to lower barriers to innovation in R&D), examined innovation drivers across a number of fronts to determine who – and what – is truly innovative.
Our findings are included in The Life Sciences Innovation Report, which covers:
- The emerging, developing, and contributing innovations from the top 1% of highly cited research
- The top 30 small molecule and biologics innovators
- Key R&D metrics and development trends
- Target and disease focus from the global investigational drugs pipeline
- IT and Pharma R&D budgets and machine learning patent activity
- Market developments in algorithms, cloud-based platforms, and mobile computing
- Regulatory perspectives influencing the adoption and policy-making of the featured innovations